Log in

Relevant bibliographies by topics / Vapour Therapy / Journal articles

To see the other types of publications on this topic, follow the link: Vapour Therapy.

Journal articles on the topic 'Vapour Therapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 8 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Vapour Therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Whiting, D., M. Noureldin, Y. Abdelmotagly, D. Butler, T. Gehring, T. Nedas, A. Emara, and R. Hindley. "Rezum water vapour therapy: Understanding retreatment." European Urology 79 (June 2021): S81. http://dx.doi.org/10.1016/s0302-2838(21)00447-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Johnston, Maximilian J., and Richard G. Hindley. "Rezum water vapour therapy for benign prostatic hyperplasia." Trends in Urology & Men's Health 10, no. 2 (March 2019): 21–24. http://dx.doi.org/10.1002/tre.684.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

LOTENS, W. A., and G. HAVENITH. "Calculation of clothing insulation and vapour resistance." Ergonomics 34, no. 2 (February 1991): 233–54. http://dx.doi.org/10.1080/00140139108967309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wallis, Belinda A., Jason Turner, John Pearn, and Roy M. Kimble. "Scalds as a result of vapour inhalation therapy in children." Burns 34, no. 4 (June 2008): 560–64. http://dx.doi.org/10.1016/j.burns.2007.07.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Westwood, Jennifer, Robert Geraghty, Patrick Jones, Bhavan P. Rai, and Bhaskar K. Somani. "Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia." Therapeutic Advances in Urology 10, no. 11 (August 12, 2018): 327–33. http://dx.doi.org/10.1177/1756287218793084.

Full text

Abstract:

Rezum is a minimally invasive transurethral water vapour therapy for benign prostatic enlargement which uses thermal energy for treatment. The short-term results show it to have good outcomes with a potential for outpatient-based treatment preserving sexual function. This review serves to provide an overview of the technique and evaluate its safety and efficacy.

APA, Harvard, Vancouver, ISO, and other styles

6

Snell, Gregory, Felix J. F. Herth, Peter Hopkins, Kimberley M. Baker, Christian Witt, Mark H. Gotfried, Arschang Valipour, et al. "Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema." European Respiratory Journal 39, no. 6 (November 10, 2011): 1326–33. http://dx.doi.org/10.1183/09031936.00092411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

McKenzie, A. L., and J. A. S. Carruth. "A comparison of gold-vapour and dye lasers for photodynamic therapy." Lasers in Medical Science 1, no. 2 (April 1986): 117–20. http://dx.doi.org/10.1007/bf02038960.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chehadi, Zeinab, Cédric Boissière, Corinne Chanéac, and Marco Faustini. "Nanoconfined water vapour as a probe to evaluate plasmonic heating." Nanoscale 12, no. 25 (2020): 13368–76. http://dx.doi.org/10.1039/d0nr01678k.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Havenith, George, Emiel den Hartog, and Svein Martini. "Heat stress in chemical protective clothing: porosity and vapour resistance." Ergonomics 54, no. 5 (May 2011): 497–507. http://dx.doi.org/10.1080/00140139.2011.558638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Johnston, Maximilian J., Mohamed Noureldin, Yehia Abdelmotagly, Louise Paramore, Tina Gehring, Timothy G. Nedas, Govindaraj Rajkumar, Amr Emara, and Richard G. Hindley. "Rezum water vapour therapy: promising early outcomes from the first UK series." BJU International 126, no. 5 (August 30, 2020): 557–58. http://dx.doi.org/10.1111/bju.15203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

LOTENS, W. A., and L. J. A. WAMMES. "Vapour transfer in two-Layer clothing due to diffusion and ventilation." Ergonomics 36, no. 10 (October 1993): 1223–40. http://dx.doi.org/10.1080/00140139308967989.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Ningthoujam, Sanjoy Singh, Anupam Das Talukdar, Kumar Singh Potsangbam, and Manabendra Dutta Choudhury. "Traditional uses of herbal vapour therapy in Manipur, North East India: An ethnobotanical survey." Journal of Ethnopharmacology 147, no. 1 (May 2013): 136–47. http://dx.doi.org/10.1016/j.jep.2012.12.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

HAVENITH, GEORGE, RONALD HEUS, and WOUTER A. LOTENS. "Clothing ventilation, vapour resistance and permeability index: changes due to posture, movement and wind." Ergonomics 33, no. 8 (August 1990): 989–1005. http://dx.doi.org/10.1080/00140139008925308.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Bruzzi, M., C. De Angelis, M. Scaringella, C. Talamonti, D. Viscomi, and M. Bucciolini. "Zero-bias operation of polycrystalline chemically vapour deposited diamond films for Intensity Modulated Radiation Therapy." Diamond and Related Materials 20, no. 2 (February 2011): 84–92. http://dx.doi.org/10.1016/j.diamond.2010.11.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

McLellan, T. M., J. I. Pope, J. B. Cain, and S. S. Cheung. "EFFECT OF METABOLIC RATE AND AMBIENT WATER VAPOUR PRESSURE ON HEAT STRAIN WITH PROTECTIVE CLOTHING 1174." Medicine &amp Science in Sports &amp Exercise 28, Supplement (May 1996): 197. http://dx.doi.org/10.1097/00005768-199605001-01173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Jones, Patrick, Giampaolo Siena, BM Zeeshan Hameed, and Bhaskar K. Somani. "Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia." Research and Reports in Urology Volume 13 (May 2021): 273–82. http://dx.doi.org/10.2147/rru.s273686.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Qian, Xiaoming, and Jintu Fan. "A quasi-physical model for predicting the thermal insulation and moisture vapour resistance of clothing." Applied Ergonomics 40, no. 4 (July 2009): 577–90. http://dx.doi.org/10.1016/j.apergo.2008.04.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Roda, E., A. Giampreti, S. Vecchio, P. Apostoli, and T. Coccini. "Mercury Vapour Long-Lasting Exposure: Lymphocyte Muscarinic Receptors as Neurochemical Markers of Accidental Intoxication." Case Reports in Medicine 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/9783876.

Full text

Abstract:

Introduction. Chronic poisoning may result in home setting after mercury (Hg) vapours inhalation from damaged devices. We report a chronic, nonoccupational Hg poisoning due to 10-year indoor exposure to mercury spillage. Case Report. A 72-year-old man with polyneuropathy of suspected toxic origin. At hospitalization, toxicological clinical evaluations confirmed the altered neurological picture documented across the last decade. Periodic blood and urine Hg levels (BHg, UHg) monitoring were performed from admission (t0), until 1 year later (t2), paralleled by blood neurochemical markers assessment, that is, lymphocytes muscarinic receptors (l-MRs). At t0: BHg and UHg were 27 and 1.4 microg/L, respectively (normal values: BHg 1–4.5; UHg 0.1–4.5), associated with l-MRs increase, 185.82 femtomoL/million lymphocytes (normal range: 8.0–16.0). At t1 (two days after DMSA-mobilization test), BHg weak reduction, paralleled by UHg 3.7-fold increase, was measured together with further l-MRs enhancement (205.43 femtomoL/million lymphocytes). At t2 (eight months after two cycles of DMSA chelating therapy ending), gradual improving of clinical manifestations was accompanied by progressive decrease of BHg and UHg (4.0 and 2.8 microg/L, resp.) and peripheral l-MRs neurochemical marker (24.89 femtomoL/million lymphocytes). Conclusion. l-MRs modulatory effect supports their use as peripheral neurochemical marker in Hg poisoning diagnosis and chelation therapy monitoring.

APA, Harvard, Vancouver, ISO, and other styles

19

Havenith, George, Ping Zhang, Kent Hatcher, and Hein Daanen. "Comparison of two tracer gas dilution methods for the determination of clothing ventilation and of vapour resistance." Ergonomics 53, no. 4 (March 22, 2010): 548–58. http://dx.doi.org/10.1080/00140130903528152.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

SHEEHAN-DARE, R. A., and J. A. COTTERILL. "Copper vapour laser treatment of port wine stains: clinical evaluation and comparison with conventional argon laser therapy." British Journal of Dermatology 128, no. 5 (May 1993): 546–49. http://dx.doi.org/10.1111/j.1365-2133.1993.tb00233.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Bismarck, Doris, Anika Dusold, Anton Heusinger, and Elisabeth Müller. "Antifungal in vitro Activity of Essential Oils against Clinical Isolates of Malassezia pachydermatis from Canine Ears: A Report from a Practice Laboratory." Complementary Medicine Research 27, no. 3 (November 27, 2019): 143–54. http://dx.doi.org/10.1159/000504316.

Full text

Abstract:

Background: The yeast Malassezia pachydermatis is a commensal but also the most isolated pathogenic yeast in canine otitis externa. Essential oils (EOs) exhibit antimicrobial activity and thus could be an alternative for treatment of otitis. Objective: The aim of this study was to analyse the in vitro efficacy of EOs against M. pachydermatis isolates from canine ears. Materials and Methods: Twenty-two EOs were tested for their in vitro activity against 15 M. pachydermatis isolates by agar disc diffusion. In addition, diluted EOs were tested and volatile antifungal activity was analysed by vapour assay. Results: Most EOs showed in vitro efficacy against M. pachydermatis. A different susceptibility pattern of tested isolates was found. Overall, the most potential EO was lemon grass. Also, cinnamon leaf, clove, manuka, Indian melissa, oregano, palmarosa, and winter savory oil exhibited a strong antifungal activity. Volatile activity was proven by the inhibiting effect in vapour assay. Conclusion: EOs show in vitro activity against M. pachydermatis. This study gives scientific background for the use of EOs in veterinary medicine. Diverse susceptibility patterns of different M. pachydermatis strains emphasise the helpfulness of an aromatogram as one lead for the best choice of an EO for therapy.

APA, Harvard, Vancouver, ISO, and other styles

22

Godsmark, Christie N., Michael J. Tipton, Michael R. Dennis, and James R. House. "Moisture vapour permeable gloves extend thermal endurance and safe work time more than other similarly permeable chemical-biological ancillary protective items." Ergonomics 61, no. 12 (December 2, 2018): 1635–45. http://dx.doi.org/10.1080/00140139.2018.1503726.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Snell, Gregory I., Peter Hopkins, Glen Westall, Lynda Holsworth, Anne Carle, and Trevor Williams. "THE FEASIBILITY AND SAFETY OF BRONCHOSCOPIC THERMAL VAPOUR ABLATION THERAPY: A NOVEL TREATMENT OF SEVERE UPPER LOBE HETEROGENOUS EMPHYSEMA." Chest 134, no. 4 (October 2008): 34S. http://dx.doi.org/10.1378/chest.134.4_meetingabstracts.s34002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Polke, Markus, Matthias Rötting, Nilab Sarmand, Johannes Krisam, Ralf Eberhardt, Felix J. F. Herth, and Daniela Gompelmann. "Interventional therapy in patients with severe emphysema: evaluation of contraindications and their incidence." Therapeutic Advances in Respiratory Disease 13 (January 2019): 175346661983549. http://dx.doi.org/10.1177/1753466619835494.

Full text

Abstract:

Background: Endoscopic and surgical interventions may be beneficial for selected patients with emphysema. Rates of treatment failure decrease when the predictors for successful therapy are known. The aim of the study was to evaluate the number of patients with severe emphysema who were not eligible for any intervention, and the reasons for their exclusion. Methods: The study was a retrospective analysis of 231 consecutive patients with advanced emphysema who were considered for interventional therapy in 2016 at the Thoraxklinik, Heidelberg, Germany. The reasons for not receiving valve or coil therapy were assessed for all patients who did not receive any therapy. Results: Of the 231 patients, 50% received an interventional therapy for lung volume reduction (LVR) (82% valve therapy, 6% coil therapy, 4.3% polymeric LVR or bronchial thermal vapour ablation, 4.3% total lung denervation, and 3.4% lung volume reduction surgery [LVRS]). A total of 115 patients did not undergo LVR. Out of these, valve or coil therapy was not performed due to one or more of the following reasons: incomplete fissure in 37% and 0%; missing target lobe in 31% and 30%; personal decision in 18% and 28%; pulmonary function test results in 8% and 15%; ventilatory failure in 4% and 4%; missing optimal standard medical care and/or continued nicotine abuse in 4% and 3%; general condition too good in less than 1% and 3%; cardiovascular comorbidities in 0% and 3%; age of patient in 0% and less than 1%. Both techniques were not performed due to one or more of the following reasons: solitary pulmonary nodule(s)/consolidation in 27%; bronchopathy in 7%; neoplasia in 2%; destroyed lung in 2%; prior LVRS in less than 1%. Conclusions: The main reason for not placing valves was an incomplete fissure and for coils a missing target lobe. Numerous additional contraindications that may exclude a patient from interventional emphysema therapy should be respected.

APA, Harvard, Vancouver, ISO, and other styles

25

Klyuchareva, S. V., I. V. Ponomarev, S. B. Topchy, A. E. Pushkareva, and Yu N. Andrusenko. "Treatment of basal cell cancer in the periorbital area using a pulsed copper vapour laser." Vestnik dermatologii i venerologii 94, no. 6 (April 17, 2019): 15–21. http://dx.doi.org/10.25208/0042-4609-2018-94-6-15-21.

Full text

Abstract:

An increase in life expectancy in developed countries is inevitably accompanied by an increase in the number of nonmelanoma skin diseases, which are primarily represented by basal cell cancer (BCC) occurring in elderly and old-age patients. The pathogenesis of such diseases is associated both with impaired proliferation and differentiation of the keratinocytes of the epidermal basal layer, as well as with the transformation of the vasculature in the papillary dermis in the vicinity of BCC. In recent years, such conditions have been increasingly treated using CO2 , neodymium, diode and pulsed-dye lasers. In many cases, these devices allow malignant BCC cells to be successfully eliminated. However, the use of near-infrared lasers in the periorbital area is limited due to a higher risk of damaging the organs of the visual system. Therefore, a search for new laser surgery methods that can be used for treating malignant skin tumours seems to be a prospective research direction.Methods. 3 male and 9 female patients diagnosed with primary BCC were treated using a copper vapour laser (Yakhroma-Med). The age of the patients varied from 34 to 77 years. Laser treatment was carried out in one session under the following irradiation parameters: the wavelength of 511 and 578 nm, the average power of up to 3 W and a series of 15 ns pulses. The pause between the pulses was 60 μs, with the exposure time ranging from 200 to 600 ms. The light spot diameter on the skin surface was 1 mm. The follow-up monitoring duration was 24 months.Results. In all the BCC patients, one session of copper vapour laser treatment allowed malignant cells in the disease area to be completely eliminated without relapses during 2 years after the therapy. The duration of skin healing in the irradiated area was 2 weeks in patients under the age of 40 years, compared to 3–4 weeks in elderly patients. After the treatment, short-term side effects, such as a slight edema, erythema and peeling, were observed.

APA, Harvard, Vancouver, ISO, and other styles

26

Bluhm, Renata E., Robert G. Bobbitt, Larry W. Welch, Alastair J. J. Wood, J. Frank Bonfiglio, Christopher Sarzen, Andrew J. Heath, and Robert A. Branch. "Elemental Mercury Vapour Toxicity, Treatment, and Prognosis After Acute, Intensive Exposure in Chloralkali Plant Workers. Part I: History, Neuropsychological Findings and Chelator effects." Human & Experimental Toxicology 11, no. 3 (May 1992): 201–10. http://dx.doi.org/10.1177/096032719201100308.

Full text

Abstract:

Mercury poisoning occurred after the acute, prolonged exposure of 53 construction workers to elemental mercury. Of those exposed, 26 were evaluated by clinical examination and tests of neuropsychological function. Patients received treatment with chelation therapy in the first weeks after exposure. Eleven of the patients with the highest mercury levels were followed in detail over an extended period. Observations included the evaluation of subjective symptoms of distress, using the 'Symptom Check List 90-Revised' (SCL-90R) and tests of visual-motor function such as 'Trailmaking Parts A and B', 'Finger Tapping', 'Stroop Colour Word Test' and 'Grooved Pegboard.' On day 85 ± 11 (mean±s.d.) after exposure, these 11 men again received either 2,3-dimercaptosuccinic acid (DMSA) or N-acetyl-D, L-penicillamine (NAP) in a short-term study designed to compare the potential to mobilize mercury and the incidence of drug-induced toxicity of these two chelating agents. Rapidly resolving metal fume fever was the earliest manifestation of symptoms. CNS symptoms and abnormal performance on neuropsychological tests persisted over the prolonged period of follow-up. There were significant correlations between neuropsychological tests and indices of mercury exposure. Serial mercury in the blood and urine verified the long half-life and large volume of distribution of mercury. Chelation therapy with both drugs resulted in the mobilization of a small fraction of the total estimated body mercury. However, DMSA was able to increase the excretion of mercury to a greater extent than NAP. These observations demonstrate that acute exposure to elemental mercury and its vapour induces acute, inorganic mercury toxicity and causes long-term, probably irreversible, neurological sequelae.

APA, Harvard, Vancouver, ISO, and other styles

27

Cope, Graham. "Electronic cigarettes: weighing up the evidence." Practice Nursing 30, no. 6 (June 2, 2019): 288–91. http://dx.doi.org/10.12968/pnur.2019.30.6.288.

Full text

Abstract:

Electronic cigarettes have been evaluated and assessed as a smoking cessation tool; however, as Graham Cope explains, a more cautious approach may be needed and users should be made aware of the potential harm of these devices Electronic cigarettes (e-cigarettes) have been evaluated to assess their safety and value as a smoking cessation tool. They were deemed to be a safer alternative to tobacco smoking. The vapour emitted was regarded as harmless and that society's attitudes should change to encourage these devices into everyday use, and therefore the regulations should be relaxed to assist the decline of tobacco smoking. However, a more cautious approach argues that nicotine replacement therapy should be used first, and only after that fails should smoking e-cigarettes, known as vaping, be done at low strength and for a limited period. Users should be made aware that nicotine from e-cigarettes could be harmful and the increasing use of attractive forms of vaping by young people is a worrying trend.

APA, Harvard, Vancouver, ISO, and other styles

28

Biddiscombe, Martyn Francis. "Inhaler Characteristics in Asthma." European Respiratory & Pulmonary Diseases 03, no. 01 (2017): 32. http://dx.doi.org/10.17925/erpd.2017.03.01.32.

Full text

Abstract:

The history of inhaled therapy goes back a surprisingly long way. More than 4,000 years ago, in India, the vapour of plants from the nightshade family placed on hot bricks was inhaled to alleviate breathing difficulties. The bronchodilators, derived from these plants, and compounds related to them, have played a significant part in therapeutic aerosol delivery over the years and remain important in the treatment of lung diseases today. The development of inhaled therapy has accelerated over the past 60 years with the arrival of the first truly portable inhaler in 1956 to relieve the symptoms of asthma. Initially, only bronchodilators were delivered from these devices, but as the true nature of asthma was revealed, inhaled corticosteroids were introduced to treat the underlying inflammation that is a major component of asthma. Further advances have led to long-acting bronchodilators becoming available, and combination therapies containing both longacting bronchodilators and corticosteroids in one inhaler. Asthma therapy has come a long way in a comparatively short time with over 230 device and drug combinations available for treating the disease. However, despite enormous investment asthma remains a huge healthcare problem. The number of people with asthma continues to grow with over 300 million people affected worldwide and 250,000 annual deaths attributed to the disease. It affects people of all ages and has a varying degree of severity. In this article, we look at the ideal characteristics for asthma inhalers and highlight some of the most important reasons for the failure of current asthma treatments.

APA, Harvard, Vancouver, ISO, and other styles

29

Haroon, Usman M., Jody Khan, Daniel McNicholas, Dearbhail NiCothain, Elysha Brennan, Hannah Graham, Niall F. Davis, James C. Forde, and Richard E. Power. "Rezum water vapour thermal therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A prospective study of early outcomes and cost analysis." European Urology Open Science 20 (September 2020): S2. http://dx.doi.org/10.1016/s2666-1683(20)35215-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hisazumi, Haruo, Katsusuke Naito, Toshimitsu Misaki, and Hajime Yamamoto. "An Experimental Study of Photodynamic Therapy using a Gold Vapor Laser." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 5, no. 3 (1985): 59–62. http://dx.doi.org/10.2530/jslsm1980.5.3_59.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Cailleau, Thaїs, Lauren R. Adams, Neha Arora, Gyoung-Dong Kang, Luke Masterson, Neki Patel, John A. Hartley, Shenlan Mao, Jay Harper, and Philip W. Howard. "Potentiation of PBD Dimers by Lipophilicity Manipulation." Current Topics in Medicinal Chemistry 19, no. 9 (June 20, 2019): 741–52. http://dx.doi.org/10.2174/1568026619666190401112517.

Full text

Abstract:

Background & Introduction: Pyrrolobenzodiazepine (PBD) dimers are highly potent DNA cross-linking agents used as warheads in Antibody Drug Conjugates (ADCs) for cancer therapy. We propose to investigate the correlation existing between the lipophilicity of those molecules and their activity (both in vitro and in vivo) as well as any effect observed during conjugation. Materials and Methods: Reaction progress was monitored by Thin-Layer Chromatography (TLC) using Merck Kieselgel 60 F254 silica gel, with a fluorescent indicator on aluminium plates. Visualisation of TLC was achieved with UV light or iodine vapour unless otherwise stated. Flash chromatography was performed using Merck Kieselgel 60 F254 silica gel. Results: We have successfully designed and synthesized a novel PBD warhead (SG3312) with enhanced physicochemical properties. The warhead also displayed increased potency in vitro. After overcoming some epimerization issues, the synthesis of enantiomerically pure payload was achieved (SG3259) and fulfilled our criteria for a simplified and more efficient conjugation. No addition of propylene glycol was required, and high DAR and excellent monomeric purity were achieved. Conclusion: The ADC (Herceptin-maia-SG3259) has been shown to release the active warhead (SG3312) upon exposure to Cathepsin B and demonstrated encouraging activity both in vitro and in vivo.

APA, Harvard, Vancouver, ISO, and other styles

32

Yamamoto, Hajime, Haruo Hisazumi, Katsusuke Naito, and Toshimitsu Misaki. "An Experimental Study of Photodynamic Therapy using a Pulsed Gold Vapor Laser." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 6, no. 3 (1986): 303–6. http://dx.doi.org/10.2530/jslsm1980.6.3_303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Scotcher, Deborah. "Diffusion Hypoxia." British Journal of Anaesthetic and Recovery Nursing 3, no. 2 (May 2002): 20–23. http://dx.doi.org/10.1017/s1742645600000942.

Full text

Abstract:

ABSTRACTThe aim of this study was to see if we could improve our practice in theatres for the benefit of the patient thus preventing diffusion hypoxia. When a patient continues to breathe from an anaesthetic circuit at the end of anaesthesia, there is a risk of delayed recovery, both by rebreathing and by the presence of anaesthetic vapour emerging from the tubes and other components of the anaesthetic equipment. It has been recommended that nitrous oxide be discontinued early in the recovery period, to monitor the patient during the first elimination phase. As hyperventilation does not influence the elimination of nitrous oxide largely, but increases the risk of subsequent hypoventilation during transport to the recovery room, hyperventilation should be avoided. It is also recommended that oxygen therapy should be used, during transport from theatre to the recovery room, regardless of the duration of nitrous oxide anaesthesia. There has proven to be a risk of Diffusion Hypoxia for at least 30 minutes after discontinuation of nitrous oxide administration in the presence of hypoventilation. The practitioner should always be cautious with heavy smokers, as they present a much greater risk of respiratory problems, and careful observation is needed for the first 5 minutes of breathing room air. Diffusion Hypoxia has proven to be avoided by administration of oxygen for 10 minutes from cessation of nitrous oxide anaesthesia.

APA, Harvard, Vancouver, ISO, and other styles

34

OHTANI, M., K. IDO, C. KAWAMOTO, and K. KIMURA. "Photodynamic Therapy Using a Gold Vapor Lasery." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 12, no. 2 (1991): 11–18. http://dx.doi.org/10.2530/jslsm1980.12.2_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Glezos, JD, JE Albrecht, and RD Gair. "Pneumonitis after Inhalation of Mercury Vapours." Canadian Respiratory Journal 13, no. 3 (2006): 150–52. http://dx.doi.org/10.1155/2006/898120.

Full text

Abstract:

A 43-year-old man presented to hospital with pneumonia but only after discharge from hospital did he admit to deliberate prior inhalation of mercury. His pulmonary involvement appeared to resolve almost completely with antibiotics and supportive care. Nevertheless, persisting elevated urinary excretion of mercury required two courses of chelation therapy. No serious systemic sequelae were observed.

APA, Harvard, Vancouver, ISO, and other styles

36

Klyuchareva, Svetlana V., O. S. Nechaeva, E. A. Belova, S. V. Guseva, A. G. Khabbus, and I. V. Ponomarev. "Treatment of lymphangioma circumscriptum using copper vapor laser." Russian Journal of Skin and Venereal Diseases 19, no. 6 (December 15, 2016): 365–69. http://dx.doi.org/10.18821/1560-9588-2016-19-6-365-369.

Full text

Abstract:

Vascular tumors occupy an important place among the benign tumors. Blood vessels tumors are studied and described in details, while there are few data about tumors of the lymphatic vessels in the literature and there are no methods of therapy. The aim of our work was to study the effectiveness of laser treatment methodfor patients with skin lymphangioma. By selective laser therapy copper vapor laser wavelength 578 nm has been selected. Patients received 1-2 treatments at 2 week intervals. The positive results were observed, efficacy was 100%, no recurrence registered. The use of copper vapor laser for treatment of lymphangioma with good cosmetic effect and long-lasting results is described.

APA, Harvard, Vancouver, ISO, and other styles

37

McVary, Kevin T., Bradley Holland, and J. Randolf Beahrs. "Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia." Prostate Cancer and Prostatic Diseases 23, no. 2 (November 18, 2019): 303–8. http://dx.doi.org/10.1038/s41391-019-0187-5.

Full text

Abstract:

Abstract Background Water vapor thermal therapy utilizes convectively delivered thermal energy to target ablation of obstructive prostatic tissue. We report results of this thermal therapy for relief of nonneurogenic complete urinary retention associated with BPH. Patients and methods We conducted a retrospective analysis of 38 catheter-dependent men with complete urinary retention consecutively enrolled in a registry in two centers: median age 75.5 years and multiple comorbidities, median prostate volume 58.5 cc (23–153), median 2 failed trials without catheter (TWOCs), and median catheter dependency 3 months (0.3–35). The Rezūm™ System thermal therapy procedure was performed in an ambulatory surgery center with conscious sedation or an office procedure room with a modified periprostatic block. Water vapor injections were customized to the configuration of the hyperplastic gland, including median lobe and/or enlarged central zone. Results Of the 38 treated patients, one was lost to follow-up and 26 of 37 (70.3%) voided spontaneously (mean of 1.6 ± 0.8 TWOCs) and were catheter free a median of 26 days (range 4–65) after the procedure; 18 of these 26 (69%) patients discontinued BPH medications. No significant differences in age, prostate volume, number of water vapor injections, or presence of the median lobe were associated with predicting a successful treatment outcome. Duration of follow-up for 20 catheter-free patients was a median of 475 days or 15.8 months (140–804 days); six patients were followed a median of 31.5 days (0–60). Adverse events were infrequent, mild, and resolved quickly including dysuria in five patients (13%), gross hematuria in four (10.5%), and UTIs in two (2.6%) with indwelling catheters. Conclusions Water vapor thermal therapy may provide an effective and safe alternative to surgical treatment in this group of catheter-dependent patients in complete urinary retention.

APA, Harvard, Vancouver, ISO, and other styles

38

Abraham, John P., Ephraim M. Sparrow, and Satish Ramadhyani. "Numerical Simulation of a BPH Thermal Therapy—A Case Study Involving TUMT." Journal of Biomechanical Engineering 129, no. 4 (December 6, 2006): 548–57. http://dx.doi.org/10.1115/1.2746377.

Full text

Abstract:

The use of numerical simulation as a means to predict the outcome of transurethral microwave thermotherapy (TUMT) is set forth in detail. The simulation was carried out as a case study of a specific TUMT procedure. The selection of the case study was based on the availability of extensive medical records which documented an extraordinary application of TUMT. Predictions were made of the time-varying temperature patterns within the prostate, the bladder, the sphincter, the pelvic floor, and the fat and connective tissue which envelop these organs. These temperature patterns provided the basis of maps which highlighted those locations where necrosis occurred. An injury integral was used to predict the extent of the necrotic tissue produced by the therapy. It was found that, for the specific case being considered, necrosis occurred not only within the prostate but also extended to the neck of the bladder and to the fatty tissue. A special feature of the simulation was the accounting of the liquid-to-vapor phase change of the interstitial water. The vapor generated by the phase change is believed to significantly enlarge the region of necrosis. By the same token, the vapor pressure is expected to cause motion of the high-temperature liquid to deep-tissue regions. The damage predicted by the numerical simulation was compared, in detail, with post-operative medical examinations and found to be corroborated.

APA, Harvard, Vancouver, ISO, and other styles

39

Liang, Jie, Haizhou Liu, Jianyu Yu, Lin Zhou, and Jia Zhu. "Plasmon-enhanced solar vapor generation." Nanophotonics 8, no. 5 (May 9, 2019): 771–86. http://dx.doi.org/10.1515/nanoph-2019-0039.

Full text

Abstract:

AbstractPlasmonic nanostructures with strong light-matter interactions have been intensively explored in the past decades. The plasmonic photothermal effect has garnered significant research interest and triggered plenty of applications, such as photothermal therapy, photothermal imaging, and photocatalysis. Recently, plasmonic nanostructures are emerging as one of the most exciting candidates for solar vapor generation, inspiring the revival of solar-thermal-based water purification technologies. Here we present a review of state-of-the-art plasmonic-enhanced solar evaporation, including the theoretical background, various designs of plasmonic materials and structures, and their potential applications. The current challenges and future perspective are outlined as well.

APA, Harvard, Vancouver, ISO, and other styles

40

Guelce, Dominique, Dominique Thomas, Dean Elterman, and Bilal Chughtai. "Recent advances in managing benign prostatic hyperplasia: The Rezūm System." F1000Research 7 (December 10, 2018): 1916. http://dx.doi.org/10.12688/f1000research.15851.1.

Full text

Abstract:

Benign Prostatic Hyperplasia is a common condition that affects 50% of men in their 50th decade. There have been many advances in the treatment of this condition, which aim to improve the patient’s quality of life. A new treatment that shows promising results is the Rezūm System, a water vapor therapy for BPH. We present the most current literature on this therapy.

APA, Harvard, Vancouver, ISO, and other styles

41

Hu, Yanni, Mei Tian, and Hong Zhang. "Molecular Imaging in Therapeutic Efficacy Assessment of Targeted Therapy for Nonsmall Cell Lung Cancer." Journal of Biomedicine and Biotechnology 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/419402.

Full text

Abstract:

Membrane distillation is a thermally driven membrane process for seawater desalination and purification at moderate temperatures and pressures. A hydrophobic micro-porous membrane is used in this process, which separates hot and cold water, allowing water vapor to pass through; while restricting the movement of liquid water, due to its hydrophobic nature. This paper provides an experimental investigation of heat and mass transfer in tubular membrane module for water desalination. Different operating parameters have been examined to determine the mass transport mechanism of water vapor. Based on the experimental results, the effects of operating parameters on permeate flux and the heat transfer analysis have been presented and discussed in details.

APA, Harvard, Vancouver, ISO, and other styles

42

Ido, Kenichi, Masahiko Ohtani, Chiaki Kawamoto, Ken Kimura, and Haruo Sato. "Experimental study of photodynamic therapy using a gold vapor laser." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 9, no. 3 (1988): 311–14. http://dx.doi.org/10.2530/jslsm1980.9.3_311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Ichii, Makoto, Seishiro Mimura, Masaharu Tatsuta, and Shigeru Okuda. "Photodynamic therapy of early gastric cancer with a copper vapor-dye laser." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 9, no. 3 (1988): 125–26. http://dx.doi.org/10.2530/jslsm1980.9.3_125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Nakamura, Tetsuya, Michimaro Ejiri, Takashi Fujisawa, Hiroyuki Akiyama, Kazushige Ejiri, Masanori Ishida, Takahiro Fujimori, Sakan Maeda, Susumu Saeki, and Shigeaki Baba. "Photodynamic Therapy for Early Gastric Cancer Using a Pulsed Gold Vapor Laser." Journal of Clinical Laser Medicine & Surgery 8, no. 5 (October 1990): 63–67. http://dx.doi.org/10.1089/clm.1990.8.63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Lantz, J.-M., C. Meyer, C. Saussine, C. Leberquier, F. Heysel, J. Miehe, J. Marescaux, R. Sultan, and M. Kedinger. "Experimental photodynamic therapy with a copper metal vapor laser in colorectal cancer." International Journal of Cancer 52, no. 3 (September 30, 1992): 491–98. http://dx.doi.org/10.1002/ijc.2910520326.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

McCaughan, James S., Rostislav D. Barabash, Dale R. Hatch, and Deborah C. McMahon. "Gold vapor laser versus tunable argon-dye laser for endobronchial photodynamic therapy." Lasers in Surgery and Medicine 19, no. 3 (1996): 347–50. http://dx.doi.org/10.1002/(sici)1096-9101(1996)19:3<347::aid-lsm11>3.0.co;2-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Deschner, Max, Marcel Tunks, and Cory Yamashita. "Electronic Cigarettes, Vaping, and Lung Disease: A Short Primer." Canadian Journal of General Internal Medicine 15, no. 4 (November 18, 2020): 24–27. http://dx.doi.org/10.22374/cjgim.v15i4.408.

Full text

Abstract:

In recent years there has been a proliferation in the practice of vaping to consume nicotine-and cannabis-based products. While evidence on the benefits and risks of electronic cigarettes (e-cigarettes) is evolving, this brief primer highlights important new information about vaping for clinicians, researchers and the public. In 2018, the Canadian government passed legislation to regulate tobacco and vaping products. We discuss evidence comparing e-cigarettes versus nicotine replacement therapy for smoking cessation and highlight limitations of this body of research. While e-cigarettes are felt to contain fewer toxins than cigarettes, the long-term effects of vaping remain unknown. Emerging data demonstrates associations between vaping and acute and chronic lung disease. We discuss the emergence of an outbreak of severe lung injury associated with e-cigarette use in the United States and similar cases in Canada. Finally, we review evidence demonstrating the growing prevalence of vaping and smoking amongst Canadian youth. RESUMECes dernières années, on a assisté à une prolifération de la pratique de la vaporisation pour consommer des produits à base de nicotine et de cannabis. Alors que les preuves sur les avantages et les risques des cigarettes électroniques (e-cigarettes) évoluent, ce bref aperçu met en lumière de nouvelles informations importantes sur le vaping pour les cliniciens, les chercheurs et le public. En 2018, le gouvernement canadien a adopté une loi pour réglementer les produits du tabac et les produits à base de vapeur. Nous examinons les données comparant les e-cigarettes et les thérapies de remplacement de la nicotine pour le sevrage tabagique et soulignons les limites de ce corpus de recherche. Bien que l’on estime que les e-cigarettes contiennent moins de toxines que les cigarettes, les effets à long terme des vapeurs restent inconnus. Les données émergentes démontrent des associations entre l’inhalation de vapeurs et les maladies pulmonaires aiguës et chroniques. Nous discutons de l’émergence d’une épidémie de lésions pulmonaires graves associées à l’utilisation des e-cigarettes aux États-Unis et de cas similaires au Canada. Enfin, nous passons en revue les preuves démontrant la prévalence croissante des vapeurs et du tabagisme chez les jeunes Canadiens.

APA, Harvard, Vancouver, ISO, and other styles

48

Kenney, W. L. "SIMULTANEOUS IN VIVO DETERMINATION OF CLOTHING INSULATION AND RESISTANCE TO VAPOR PERMEATION." Medicine & Science in Sports & Exercise 24, Supplement (May 1992): S152. http://dx.doi.org/10.1249/00005768-199205001-00912.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Klyuchareva, Svetlana V., Igor V. Ponomarev, and Alexandra E. Pushkareva. "THERAPY OF SKIN VASCULAR MALFORMATIONS USING COPPER VAPOR LASER AND PULSED DYE LASER." Vestnik dermatologii i venerologii 94, no. 1 (April 24, 2018): 67–77. http://dx.doi.org/10.25208/0042-4609-2018-94-1-67-77.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

KONDA, Y., H. AKIYAMA, T. NAKAMURA, T. FUJIMORI, J. YANO, K. EJIRI, and M. EJIRI. "APPLICATION OF GOLD VAPOR LASER FOR PHOTO -DYNAMIC THERAPY OF EARLY GASTRIC CANCER." JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE 10, no. 3 (1989): 213–16. http://dx.doi.org/10.2530/jslsm1980.10.3_213.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!